Protein kinase inhibitors are used in targeted therapy to treat a range of cancers, such as leukemia, lung cancer, renal cancer, melanoma, breast cancer and thyroid cancer. They stop cancer cell growth and prevent further spreading of cancer by inhibiting the enzyme BCR-ABL tyrosine kinase. Commonly prescribed protein kinase inhibitors include Cabometyx (cabozantinib), Sprycel (dasatinib), and Gleevec (imatinib).
Drugs classified as Protein Kinase Inhibitors are frequently used to treat the following conditions:
Click on a drug below in order to find information and discounted prices at pharmacies near you.